Lataa...
New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor)
Systemic lupus erythematosus (SLE) is a systemic autoimmune rheumatic disease of unknown etiology, characterized by overproduction of organ-specific autoantibodies to various components of the cell nucleus and the development of immune-inflammatory damage to internal organs. According to modern conc...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
IMA-PRESS LLC
2021-10-01
|
| Sarja: | Научно-практическая ревматология |
| Aiheet: | |
| Linkit: | https://rsp.mediar-press.net/rsp/article/view/3072 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|